Publisert 03.01.2018

Succesfull placement of share issue December 2017

According to resolutions by the Board of Directors on December 15th 2017 a limited private placement of a total of 129.729 shares at a price of 17.15 NOK per share was subscribed by new shareholders  on December 18th 2017. 

For further details and info contact: 

Chairman Board of Directors Tore H. Rasmussen at or mobile +47 95892548 

Present shareholders/shares in Regenics AS


Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.